These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 18643838)
1. Regulation of adipose triglyceride lipase by rosiglitazone. Liu LF; Purushotham A; Wendel AA; Koba K; DeIuliis J; Lee K; Belury MA Diabetes Obes Metab; 2009 Feb; 11(2):131-42. PubMed ID: 18643838 [TBL] [Abstract][Full Text] [Related]
2. PPARgamma regulates adipose triglyceride lipase in adipocytes in vitro and in vivo. Kershaw EE; Schupp M; Guan HP; Gardner NP; Lazar MA; Flier JS Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1736-45. PubMed ID: 17848638 [TBL] [Abstract][Full Text] [Related]
3. The adipose tissue triglyceride lipase ATGL/PNPLA2 is downregulated by insulin and TNF-alpha in 3T3-L1 adipocytes and is a target for transactivation by PPARgamma. Kim JY; Tillison K; Lee JH; Rearick DA; Smas CM Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E115-27. PubMed ID: 16705060 [TBL] [Abstract][Full Text] [Related]
5. Isoproterenol, TNFalpha, and insulin downregulate adipose triglyceride lipase in 3T3-L1 adipocytes. Kralisch S; Klein J; Lossner U; Bluher M; Paschke R; Stumvoll M; Fasshauer M Mol Cell Endocrinol; 2005 Aug; 240(1-2):43-9. PubMed ID: 16009485 [TBL] [Abstract][Full Text] [Related]
6. Obestatin and Rosiglitazone Differentially Modulate Lipid Metabolism Through Peroxisome Proliferator-activated Receptor-γ (PPARγ) in Pre-adipose and Mature 3T3-L1 Cells. B G M; Manjappara UV Cell Biochem Biophys; 2021 Mar; 79(1):73-85. PubMed ID: 33432549 [TBL] [Abstract][Full Text] [Related]
7. 6-gingerol inhibits rosiglitazone-induced adipogenesis in 3T3-L1 adipocytes. Tzeng TF; Chang CJ; Liu IM Phytother Res; 2014 Feb; 28(2):187-92. PubMed ID: 23519881 [TBL] [Abstract][Full Text] [Related]
8. Coordinated transcriptional control of adipocyte triglyceride lipase ( Roy D; Farabaugh KT; Wu J; Charrier A; Smas C; Hatzoglou M; Thirumurugan K; Buchner DA J Biol Chem; 2017 Sep; 292(36):14827-14835. PubMed ID: 28726642 [TBL] [Abstract][Full Text] [Related]
9. The potential insulin sensitizing and glucose lowering effects of a novel indole derivative in vitro and in vivo. Li YY; Wu HS; Tang L; Feng CR; Yu JH; Li Y; Yang YS; Yang B; He QJ Pharmacol Res; 2007 Oct; 56(4):335-43. PubMed ID: 17889553 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of divergent effects of activated peroxisome proliferator-activated receptor-γ on mitochondrial citrate carrier expression in 3T3-L1 fibroblasts and mature adipocytes. Bonofiglio D; Santoro A; Martello E; Vizza D; Rovito D; Cappello AR; Barone I; Giordano C; Panza S; Catalano S; Iacobazzi V; Dolce V; Andò S Biochim Biophys Acta; 2013 Jun; 1831(6):1027-36. PubMed ID: 23370576 [TBL] [Abstract][Full Text] [Related]
11. Higher levels of ATGL are associated with exercise-induced enhancement of lipolysis in rat epididymal adipocytes. Ogasawara J; Sakurai T; Kizaki T; Ishibashi Y; Izawa T; Sumitani Y; Ishida H; Radak Z; Haga S; Ohno H PLoS One; 2012; 7(7):e40876. PubMed ID: 22815850 [TBL] [Abstract][Full Text] [Related]
13. The PPARgamma agonist rosiglitazone enhances rat brown adipose tissue lipogenesis from glucose without altering glucose uptake. Festuccia WT; Blanchard PG; Turcotte V; Laplante M; Sariahmetoglu M; Brindley DN; Richard D; Deshaies Y Am J Physiol Regul Integr Comp Physiol; 2009 May; 296(5):R1327-35. PubMed ID: 19211718 [TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor-gamma regulates the expression and function of very-low-density lipoprotein receptor. Tao H; Aakula S; Abumrad NN; Hajri T Am J Physiol Endocrinol Metab; 2010 Jan; 298(1):E68-79. PubMed ID: 19861583 [TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidic acid inhibits adipocyte differentiation via lysophosphatidic acid 1 receptor-dependent down-regulation of peroxisome proliferator-activated receptor gamma2. Simon MF; Daviaud D; Pradère JP; Grès S; Guigné C; Wabitsch M; Chun J; Valet P; Saulnier-Blache JS J Biol Chem; 2005 Apr; 280(15):14656-62. PubMed ID: 15710620 [TBL] [Abstract][Full Text] [Related]
16. PPARgamma agonism increases rat adipose tissue lipolysis, expression of glyceride lipases, and the response of lipolysis to hormonal control. Festuccia WT; Laplante M; Berthiaume M; Gélinas Y; Deshaies Y Diabetologia; 2006 Oct; 49(10):2427-36. PubMed ID: 16906479 [TBL] [Abstract][Full Text] [Related]
17. Rosiglitazone modulates insulin-induced plasma membrane area changes in single 3T3-L1 adipocytes. Velebit J; Kovacic PB; Prebil M; Chowdhury HH; Grilc S; Kreft M; Jensen J; Isenović ER; Zorec R J Membr Biol; 2008 Jun; 223(3):141-9. PubMed ID: 18754069 [TBL] [Abstract][Full Text] [Related]
18. The role of prolyl hydroxylase domain protein (PHD) during rosiglitazone-induced adipocyte differentiation. Kim J; Kwak HJ; Cha JY; Jeong YS; Rhee SD; Cheon HG J Biol Chem; 2014 Jan; 289(5):2755-64. PubMed ID: 24338020 [TBL] [Abstract][Full Text] [Related]
19. Lentinan depresses 3T3-L1 fat cell formation by inhibiting PPARγ/AKT signaling pathway. Li DG; Li JL; Sun DQ; Sun XB; Sun XG; Liu Q Genet Mol Res; 2015 Jul; 14(3):8084-90. PubMed ID: 26214491 [TBL] [Abstract][Full Text] [Related]
20. Suppression of adipocyte differentiation and lipid accumulation by stearidonic acid (SDA) in 3T3-L1 cells. Li Y; Rong Y; Bao L; Nie B; Ren G; Zheng C; Amin R; Arnold RD; Jeganathan RB; Huggins KW Lipids Health Dis; 2017 Sep; 16(1):181. PubMed ID: 28946872 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]